Answers are grounded in this paper and cite their sources.
Chronic rhinosinusitis is a chronic inflammatory disease of the upper airways, for which treatment options include medical or surgical therapy. However, there are limitations to conservative treatment strategies, such as the relapse of nasal polyps. In this review, we discuss the rising role of biomolecular mechanisms associated with various biologics that have been approved or are undergoing clinical trials to treat chronic rhinosinusitis. We also highlight the potential molecular therapeutic targets for managing and treating chronic rhinosinusitis.
No takes yet. Share an insight, caveat, or question.
Tai et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: